Market Cap 712.16M
Revenue (ttm) 333.79M
Net Income (ttm) 52.55M
EPS (ttm) N/A
PE Ratio 11.17
Forward PE N/A
Profit Margin 15.74%
Debt to Equity Ratio 0.00
Volume 877,500
Avg Vol 1,551,134
Day's Range N/A - N/A
Shares Out 55.68M
Stochastic %K 19%
Beta 2.19
Analysts Strong Sell
Price Target $28.00

Company Profile

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. T...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 415 287 2300
Fax: 415 287 2450
Website: caredx.com
Address:
8000 Marina Boulevard, Brisbane, South San Francisco, United States
Trademotions
Trademotions Jul. 25 at 3:11 PM
$CDNA looks like accumulation to me
0 · Reply
KeepThisRollin
KeepThisRollin Jul. 24 at 3:51 PM
$CDNA Those $15 & $17.50 August, September calls tho 👀🚀💲 #bullish
0 · Reply
KeepThisRollin
KeepThisRollin Jul. 24 at 2:56 PM
$CDNA The insiders like Maag Peter Director and others will start pouring in, at this price and this will RUN! #BULLISH 🚀🚀🚀💲💲💲
0 · Reply
Trademotions
Trademotions Jul. 23 at 4:06 PM
0 · Reply
GoldenTicket1
GoldenTicket1 Jul. 23 at 2:14 PM
$CDNA The CEO of CareDx came out and stated there should be no change based on this draft around Medicare coverage as it relates to CareDx.
0 · Reply
GoldenTicket1
GoldenTicket1 Jul. 23 at 1:37 PM
$CDNA CareDx to Report Second Quarter 2025 Financial Results BRISBANE, Calif., July 23, 2025--(BUSINESS WIRE --CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the second quarter 2025 after market close on Wednesday, August 6, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing 1-800-274-8461 for domestic callers or 1-203-518-9814 for international callers. Please reference Conference ID: CareDx. To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com
0 · Reply
GoldenTicket1
GoldenTicket1 Jul. 23 at 5:26 AM
$CDNA Buying the dip on this diagnostic name after 'significant overreaction' CareDx Shares of CareDx, Inc. (CDNA) fell around 40% this past week. CareDx provides diagnostic solutions for transplant patients and has several products on the market. The trigger for the decline was a draft of a Local Coverage Determination, or LCD, related to organ transplants. Specifically related to molecular testing for solid organ allograft rejection. The fears were this could potentially lower the Medicare reimbursement for some of the company’s diagnostic tests. However, late in the week, the CEO of CareDx came out and stated there should be no change based on this draft around Medicare coverage as it relates to CareDx. A healthcare research firm called Nephron Research upgraded CDNA shares to a "Buy" with a $28 price target on the dip in the stock, which ended the week just below the $12 level. 🚀🚀🚀🚀🚀
0 · Reply
11thestate
11thestate Jul. 22 at 11:23 PM
$CDNA reached a settlement with investors over claims that it misled them about revenue quality and compliance with Medicare billing rules. Who’s eligible? Anyone who bought and held $CDNA stock between April 30, 2020, and November 3, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? The payout per share is $0.32 — but if only ~25% of eligible investors file, the effective payout could increase. Can I still file? Yes — late claims are being considered, pending court approval. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/caredx-investor-settlement
1 · Reply
nUme22
nUme22 Jul. 22 at 4:41 PM
$CDNA 7-8 bottom ??
1 · Reply
KeepThisRollin
KeepThisRollin Jul. 22 at 3:43 PM
$CDNA TRUMP rn, White house meeting, about Pharma, medical and Philippines BIG PUMP incoming 🚀🚀🚀💲💲💲
0 · Reply
Latest News on CDNA
CareDx to Report Second Quarter 2025 Financial Results

Jul 23, 2025, 7:05 AM EDT - 4 days ago

CareDx to Report Second Quarter 2025 Financial Results


CareDx Announces Repurchase of 5% of Outstanding Shares

Jun 3, 2025, 4:30 PM EDT - 7 weeks ago

CareDx Announces Repurchase of 5% of Outstanding Shares


CareDx to Participate in Upcoming Investor Conferences

May 13, 2025, 4:01 PM EDT - 2 months ago

CareDx to Participate in Upcoming Investor Conferences


CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 8:39 PM EDT - 3 months ago

CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript


CareDx Reports First Quarter 2025 Results

Apr 30, 2025, 4:05 PM EDT - 3 months ago

CareDx Reports First Quarter 2025 Results


CareDx to Report First Quarter 2025 Financial Results

Apr 8, 2025, 7:05 AM EDT - 3 months ago

CareDx to Report First Quarter 2025 Financial Results


CareDx, Inc (CDNA) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 10:01 PM EST - 5 months ago

CareDx, Inc (CDNA) Q4 2024 Earnings Call Transcript


Final Trades: NRG Energy, MP Materials, CareDx and Applovin

Feb 10, 2025, 2:08 PM EST - 5 months ago

Final Trades: NRG Energy, MP Materials, CareDx and Applovin

APP MP NRG


CareDx: Top Of My Shopping List For 2025

Dec 25, 2024, 1:23 AM EST - 7 months ago

CareDx: Top Of My Shopping List For 2025


CareDx, Inc (CDNA) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 10:05 PM EST - 9 months ago

CareDx, Inc (CDNA) Q3 2024 Earnings Call Transcript


CareDx Appoints Jing Huang Chief Data and AI Officer

Oct 9, 2024, 7:05 AM EDT - 10 months ago

CareDx Appoints Jing Huang Chief Data and AI Officer


CareDx to Host Investor Day on October 15, 2024

Oct 8, 2024, 4:05 PM EDT - 10 months ago

CareDx to Host Investor Day on October 15, 2024


CareDx Inc (CDNA) Trading 6.16% Higher on Oct 2

Oct 2, 2024, 12:06 PM EDT - 10 months ago

CareDx Inc (CDNA) Trading 6.16% Higher on Oct 2


CareDx, Inc. (CDNA) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 8:03 PM EDT - 1 year ago

CareDx, Inc. (CDNA) Q2 2024 Earnings Call Transcript


CareDx to Report Second Quarter 2024 Financial Results

Jul 16, 2024, 7:05 AM EDT - 1 year ago

CareDx to Report Second Quarter 2024 Financial Results


Trademotions
Trademotions Jul. 25 at 3:11 PM
$CDNA looks like accumulation to me
0 · Reply
KeepThisRollin
KeepThisRollin Jul. 24 at 3:51 PM
$CDNA Those $15 & $17.50 August, September calls tho 👀🚀💲 #bullish
0 · Reply
KeepThisRollin
KeepThisRollin Jul. 24 at 2:56 PM
$CDNA The insiders like Maag Peter Director and others will start pouring in, at this price and this will RUN! #BULLISH 🚀🚀🚀💲💲💲
0 · Reply
Trademotions
Trademotions Jul. 23 at 4:06 PM
0 · Reply
GoldenTicket1
GoldenTicket1 Jul. 23 at 2:14 PM
$CDNA The CEO of CareDx came out and stated there should be no change based on this draft around Medicare coverage as it relates to CareDx.
0 · Reply
GoldenTicket1
GoldenTicket1 Jul. 23 at 1:37 PM
$CDNA CareDx to Report Second Quarter 2025 Financial Results BRISBANE, Calif., July 23, 2025--(BUSINESS WIRE --CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the second quarter 2025 after market close on Wednesday, August 6, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing 1-800-274-8461 for domestic callers or 1-203-518-9814 for international callers. Please reference Conference ID: CareDx. To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredx.com
0 · Reply
GoldenTicket1
GoldenTicket1 Jul. 23 at 5:26 AM
$CDNA Buying the dip on this diagnostic name after 'significant overreaction' CareDx Shares of CareDx, Inc. (CDNA) fell around 40% this past week. CareDx provides diagnostic solutions for transplant patients and has several products on the market. The trigger for the decline was a draft of a Local Coverage Determination, or LCD, related to organ transplants. Specifically related to molecular testing for solid organ allograft rejection. The fears were this could potentially lower the Medicare reimbursement for some of the company’s diagnostic tests. However, late in the week, the CEO of CareDx came out and stated there should be no change based on this draft around Medicare coverage as it relates to CareDx. A healthcare research firm called Nephron Research upgraded CDNA shares to a "Buy" with a $28 price target on the dip in the stock, which ended the week just below the $12 level. 🚀🚀🚀🚀🚀
0 · Reply
11thestate
11thestate Jul. 22 at 11:23 PM
$CDNA reached a settlement with investors over claims that it misled them about revenue quality and compliance with Medicare billing rules. Who’s eligible? Anyone who bought and held $CDNA stock between April 30, 2020, and November 3, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? The payout per share is $0.32 — but if only ~25% of eligible investors file, the effective payout could increase. Can I still file? Yes — late claims are being considered, pending court approval. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/caredx-investor-settlement
1 · Reply
nUme22
nUme22 Jul. 22 at 4:41 PM
$CDNA 7-8 bottom ??
1 · Reply
KeepThisRollin
KeepThisRollin Jul. 22 at 3:43 PM
$CDNA TRUMP rn, White house meeting, about Pharma, medical and Philippines BIG PUMP incoming 🚀🚀🚀💲💲💲
0 · Reply
PencilNeckGeek
PencilNeckGeek Jul. 22 at 2:30 PM
$CDNA expected it to be close to $14 by now.
1 · Reply
andftbl
andftbl Jul. 22 at 11:15 AM
$CDNA reversal?
0 · Reply
KeepThisRollin
KeepThisRollin Jul. 21 at 11:56 PM
$CDNA $11.48 Market Open tomorrow BULLISH 💲💲🚀🚀🚀
0 · Reply
GoldenTicket1
GoldenTicket1 Jul. 21 at 9:49 PM
$CDNA Overdone. Going back to $16-$17
1 · Reply
BlakeCanyon50
BlakeCanyon50 Jul. 21 at 8:57 PM
$CDNA Sold at today’s high, on the button! 👆🏽🤘🏼👆🏽❤️
0 · Reply
RunnerSignals
RunnerSignals Jul. 21 at 8:23 PM
market warriors flipped the script! $HAIN $GETY $CDNA $AEHR $TDS started red, closed green
0 · Reply
Alvi722
Alvi722 Jul. 21 at 5:29 PM
$CDNA 14 -15 would be hourly and 4 hour resistance if it keeps going. $SPY $UNH
0 · Reply
KeepThisRollin
KeepThisRollin Jul. 21 at 5:03 PM
0 · Reply
KeepThisRollin
KeepThisRollin Jul. 21 at 5:03 PM
$CDNA $12.70 Then bounce, Bull run incoming. BULLISH 💲💲💲🚀🚀🚀 151K @ $12.70 waiting 👀
0 · Reply
BrokeUntilFriday
BrokeUntilFriday Jul. 21 at 3:28 PM
$CDNA - Just a thing of beauty this morning! 🤑
0 · Reply
KeepThisRollin
KeepThisRollin Jul. 21 at 3:15 PM
$CDNA Easy back over $13.00, $14.00 + EOW BULLISH 💲💲💲🚀🚀🚀⏫⏫
0 · Reply
BlakeCanyon50
BlakeCanyon50 Jul. 21 at 3:00 PM
$CDNA Sold $13.07. Boom! GLTA.
0 · Reply